However, in a population-based retrospective cohort study examining management after acute myocardial infarction, people with MS were less likely to undergo cardiac catheterization within 30 days of hospitalization (OR 0.61; 0.49-0.77), had a longer time to revascularization (HR 0.78; 0.69-0.88), and were less likely to fill a prescription for beta-blockers, high dose statins, an ACE- inhibitor/angiotensin receptor blocker, or dual anti-platelet therapy than people without MS (14). Here, ACE is linked to acute myocardial infarction.